20/120
0.8 / 5 stars
All 120 Win/Lose results shown below
XCUR Roast Me summary
EXICURE, INC. (XCUR). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseXCUR / S&P -51.12% / 15.20% |
LoseXCUR / S&P XCUR unavailable / 15.00% |
LoseXCUR / S&P XCUR unavailable / 50.40% |
| 2026-Q10/3 |
LoseXCUR / S&P -21.49% / -4.33% |
LoseXCUR / S&P XCUR unavailable / 11.30% |
LoseXCUR / S&P XCUR unavailable / 27.70% |
| 2025-Q41/3 |
WinXCUR / S&P 32.52% / 2.65% |
LoseXCUR / S&P -100.00% / 9.00% |
LoseXCUR / S&P XCUR unavailable / 13.40% |
| 2025-Q30/3 |
LoseXCUR / S&P -41.90% / 8.12% |
LoseXCUR / S&P -100.00% / 4.61% |
LoseXCUR / S&P XCUR unavailable / 13.45% |
| 2025-Q20/3 |
LoseXCUR / S&P -47.23% / 10.94% |
LoseXCUR / S&P -100.00% / 4.83% |
LoseXCUR / S&P XCUR unavailable / 10.63% |
| 2025-Q11/3 |
WinXCUR / S&P -2.41% / -4.27% |
LoseXCUR / S&P -100.00% / 4.98% |
LoseXCUR / S&P XCUR unavailable / 10.57% |
| 2024-Q41/3 |
WinXCUR / S&P 293.95% / 2.41% |
LoseXCUR / S&P XCUR unavailable / 5.25% |
LoseXCUR / S&P XCUR unavailable / 6.15% |
| 2024-Q31/3 |
WinXCUR / S&P 116.88% / 5.89% |
LoseXCUR / S&P -97.70% / 5.89% |
LoseXCUR / S&P XCUR unavailable / 6.11% |
| 2024-Q20/3 |
LoseXCUR / S&P -46.84% / 4.28% |
LoseXCUR / S&P -97.90% / 5.38% |
LoseXCUR / S&P -369.64% / 5.12% |
| 2024-Q10/3 |
LoseXCUR / S&P 3.79% / 10.56% |
LoseXCUR / S&P -98.10% / 5.71% |
LoseXCUR / S&P -794.29% / 5.59% |
| 2023-Q40/3 |
LoseXCUR / S&P -19.44% / 11.69% |
LoseXCUR / S&P -100.00% / 6.81% |
LoseXCUR / S&P XCUR unavailable / 7.78% |
| 2023-Q31/3 |
LoseXCUR / S&P -45.04% / -3.27% |
WinXCUR / S&P 137.45% / 7.52% |
LoseXCUR / S&P XCUR unavailable / -5.03% |
| 2023-Q22/3 |
WinXCUR / S&P 50.40% / 8.74% |
WinXCUR / S&P 584.21% / 9.50% |
LoseXCUR / S&P XCUR unavailable / -8.57% |
| 2023-Q11/3 |
LoseXCUR / S&P -24.26% / 7.50% |
WinXCUR / S&P 2320.37% / 10.77% |
LoseXCUR / S&P XCUR unavailable / -15.69% |
| 2022-Q40/3 |
LoseXCUR / S&P -26.75% / 7.56% |
LoseXCUR / S&P XCUR unavailable / 11.88% |
LoseXCUR / S&P XCUR unavailable / -17.99% |
| 2022-Q30/3 |
LoseXCUR / S&P -27.31% / -4.88% |
LoseXCUR / S&P XCUR unavailable / 13.47% |
LoseXCUR / S&P XCUR unavailable / -1.41% |
| 2022-Q20/3 |
LoseXCUR / S&P -64.00% / -16.10% |
LoseXCUR / S&P -4.97% / 13.71% |
LoseXCUR / S&P XCUR unavailable / 11.04% |
| 2022-Q11/3 |
WinXCUR / S&P -0.99% / -4.60% |
LoseXCUR / S&P -87.12% / 15.97% |
LoseXCUR / S&P XCUR unavailable / 42.23% |
| 2021-Q40/3 |
LoseXCUR / S&P -83.17% / 11.03% |
LoseXCUR / S&P -102.91% / 15.00% |
LoseXCUR / S&P XCUR unavailable / 96.40% |
| 2021-Q30/3 |
LoseXCUR / S&P -20.00% / 0.58% |
LoseXCUR / S&P -114.66% / 10.77% |
LoseXCUR / S&P XCUR unavailable / 69.42% |
| 2021-Q20/3 |
LoseXCUR / S&P -31.19% / 8.55% |
LoseXCUR / S&P -75.39% / 6.58% |
LoseXCUR / S&P XCUR unavailable / 51.81% |
| 2021-Q11/3 |
WinXCUR / S&P 23.16% / 6.17% |
LoseXCUR / S&P -19.39% / -1.06% |
LoseXCUR / S&P XCUR unavailable / 7.39% |
| 2020-Q41/3 |
LoseXCUR / S&P 1.14% / 12.15% |
WinXCUR / S&P 1181.87% / -3.72% |
LoseXCUR / S&P XCUR unavailable / -33.42% |
| 2020-Q31/3 |
LoseXCUR / S&P -28.28% / 8.93% |
WinXCUR / S&P 1591.83% / -2.04% |
LoseXCUR / S&P XCUR unavailable / -27.10% |
| 2020-Q22/3 |
WinXCUR / S&P 64.86% / 20.54% |
WinXCUR / S&P 2748.08% / -0.46% |
LoseXCUR / S&P XCUR unavailable / -27.11% |
| 2020-Q11/3 |
LoseXCUR / S&P -48.25% / -19.60% |
WinXCUR / S&P 9670.09% / 3.47% |
LoseXCUR / S&P XCUR unavailable / -14.75% |
| 2019-Q42/3 |
WinXCUR / S&P 13.04% / 9.07% |
WinXCUR / S&P 998.31% / 5.36% |
LoseXCUR / S&P XCUR unavailable / 2.99% |
| 2019-Q30/3 |
LoseXCUR / S&P -9.64% / 1.70% |
LoseXCUR / S&P -55.05% / 5.02% |
LoseXCUR / S&P XCUR unavailable / 0.21% |
| 2019-Q21/3 |
WinXCUR / S&P 19.15% / 4.30% |
LoseXCUR / S&P -88.77% / 6.64% |
LoseXCUR / S&P XCUR unavailable / 8.65% |
| 2019-Q10/3 |
LoseXCUR / S&P -33.62% / 13.65% |
LoseXCUR / S&P -98.54% / 8.12% |
LoseXCUR / S&P XCUR unavailable / 14.29% |
| 2018-Q41/3 |
WinXCUR / S&P -13.45% / -13.52% |
LoseXCUR / S&P -98.79% / 9.05% |
LoseXCUR / S&P XCUR unavailable / 18.23% |
| 2018-Q30/3 |
LoseXCUR / S&P -28.25% / 7.71% |
LoseXCUR / S&P -73.45% / 10.21% |
LoseXCUR / S&P XCUR unavailable / 19.06% |
| 2018-Q20/3 |
LoseXCUR / S&P XCUR unavailable / 3.43% |
LoseXCUR / S&P -20.11% / 9.03% |
LoseXCUR / S&P XCUR unavailable / 14.46% |
| 2018-Q10/3 |
LoseXCUR / S&P XCUR unavailable / -0.76% |
LoseXCUR / S&P XCUR unavailable / 7.68% |
LoseXCUR / S&P XCUR unavailable / 12.46% |
| 2017-Q41/3 |
LoseXCUR / S&P XCUR unavailable / 6.64% |
WinXCUR / S&P 838.13% / 7.03% |
LoseXCUR / S&P XCUR unavailable / 13.82% |
| 2017-Q30/3 |
LoseXCUR / S&P XCUR unavailable / 4.48% |
LoseXCUR / S&P XCUR unavailable / 5.68% |
LoseXCUR / S&P XCUR unavailable / 17.57% |
| 2017-Q20/3 |
LoseXCUR / S&P XCUR unavailable / 3.09% |
LoseXCUR / S&P XCUR unavailable / 4.83% |
LoseXCUR / S&P XCUR unavailable / 17.74% |
| 2017-Q10/3 |
LoseXCUR / S&P XCUR unavailable / 6.07% |
LoseXCUR / S&P XCUR unavailable / 3.67% |
LoseXCUR / S&P XCUR unavailable / 13.32% |
| 2016-Q40/3 |
LoseXCUR / S&P XCUR unavailable / 3.82% |
LoseXCUR / S&P XCUR unavailable / 2.09% |
LoseXCUR / S&P XCUR unavailable / 7.05% |
| 2016-Q30/3 |
LoseXCUR / S&P XCUR unavailable / 3.85% |
LoseXCUR / S&P XCUR unavailable / 0.20% |
LoseXCUR / S&P XCUR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | XCUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -76.55% | 20.78% |
| Annualized return | -76.55% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | XCUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.36% | 83.14% |
| Annualized return | -63.59% | 12.86% |
10Y · 2018-05-22 to 2026-08-28
| Metric | XCUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.72% | 319.30% |
| Annualized return | -44.39% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |